These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3293091

  • 1. The role of corticotropin-releasing factor in the pathogenesis of major depression.
    Nemeroff CB.
    Pharmacopsychiatry; 1988 Mar; 21(2):76-82. PubMed ID: 3293091
    [Abstract] [Full Text] [Related]

  • 2. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF, Bao AM, Lucassen PJ.
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [Abstract] [Full Text] [Related]

  • 3. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.
    Owens MJ, Bissette G, Nemeroff CB.
    Synapse; 1989 May; 4(3):196-202. PubMed ID: 2575286
    [Abstract] [Full Text] [Related]

  • 4. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [Abstract] [Full Text] [Related]

  • 5. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G, Ansseau M, Legros JJ.
    Encephale; 2001 Feb; 27(3):245-59. PubMed ID: 11488255
    [Abstract] [Full Text] [Related]

  • 10. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
    Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ.
    J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
    [Abstract] [Full Text] [Related]

  • 11. Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system.
    Udelsman R, Harwood JP, Millan MA, Chrousos GP, Goldstein DS, Zimlichman R, Catt KJ, Aguilera G.
    Nature; 2000 Aug; 319(6049):147-50. PubMed ID: 3001536
    [Abstract] [Full Text] [Related]

  • 12. Role of brain, pituitary and spleen corticotropin-releasing factor receptors in the stress response.
    De Souza EB, Grigoriadis DE, Webster EL.
    Methods Achiev Exp Pathol; 1991 Aug; 14():23-44. PubMed ID: 1658548
    [Abstract] [Full Text] [Related]

  • 13. Persistent changes in corticotropin-releasing factor systems due to early life stress: relationship to the pathophysiology of major depression and post-traumatic stress disorder.
    Heim C, Owens MJ, Plotsky PM, Nemeroff CB.
    Psychopharmacol Bull; 1997 Aug; 33(2):185-92. PubMed ID: 9230630
    [Abstract] [Full Text] [Related]

  • 14. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.
    Owens MJ, Vargas MA, Knight DL, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):349-56. PubMed ID: 1649300
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiological actions of corticotropin-releasing factor in the central nervous system.
    Siggins GR, Gruol D, Aldenhoff J, Pittman Q.
    Fed Proc; 1985 Jan 01; 44(1 Pt 2):237-42. PubMed ID: 3155696
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antidepressant actions on brain noradrenergic neurons.
    Valentino RJ, Curtis AL, Parris DG, Wehby RG.
    J Pharmacol Exp Ther; 1990 May 01; 253(2):833-40. PubMed ID: 2338658
    [Abstract] [Full Text] [Related]

  • 18. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor.
    Nemeroff CB.
    Neuropsychopharmacology; 1992 Feb 01; 6(2):69-75. PubMed ID: 1610487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal.
    Nemeroff CB.
    J Clin Psychiatry; 1989 May 01; 50 Suppl():13-20; discussion 21-2. PubMed ID: 2654128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.